Drugs / Insulin lispro mid mixture (MM)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00377858 | Aug 2006 → Sep 2008 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin lispro mid mixture (MM) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00377858 ↗ |
| Route | Subcutaneous | “Patient specific adjusted dose, three times a day (TID), subcutaneous (SC) injection x 36 weeks” NCT00377858 ↗ |